USA |NASDAQ |USD |ADR
| Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
|---|---|---|---|---|
| Nov 5, 2021 (est) | Sep 30, 2021 | - | $-0.88 | $-0.71 |
| Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
|---|---|---|---|---|
| Nov 5, 2021 (est) | Sep 30, 2021 | - | $11.18M | $9.24M |
Cellectis's next estimated earnings date (based on same quarter last year's date) is Nov 5, 2021 for the fiscal quarter ending Sep 30, 2021.
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 8 | $-0.60 | $-1.05 | $-0.02 |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 10 | $-2.53 | $-3.23 | $-1.68 |
| Dec 2022 | 10 | $-2.98 | $-4.40 | $-0.86 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2021 | 0 / 1 | $-0.48 | $-0.50 | $-0.64 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2021 | 0 / 1 | $-2.39 | $-2.37 | $-2.20 |
| Dec 2022 | 0 / 1 | $-2.83 | $-2.82 | $-2.84 |
| Period End | # of Analysts | Revenue Forecast | Low Revenue Forecast | High Revenue Forecast |
|---|---|---|---|---|
| Dec 2021 | 8 | $23.21M | $11.00M | $60.10M |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 11 | $76.90M | $51.40M | $112.18M |
| Dec 2022 | 11 | $72.28M | $16.00M | $169.62M |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Aug 5, 2021 | Jun 2021 | $-0.73 | $-0.88 | -21.38% |
| May 6, 2021 | Mar 2021 | $-0.81 | $-0.28 | 65.49% |
| Mar 4, 2021 | Dec 2020 | $-0.80 | $-0.95 | -18.38% |
| Nov 5, 2020 | Sep 2020 | $-0.61 | $-0.71 | -15.77% |
| Aug 5, 2020 | Jun 2020 | $-0.74 | $-0.76 | -2.70% |
| May 6, 2020 | Mar 2020 | $-0.65 | $0.47 | 172.43% |
| Mar 4, 2020 | Dec 2019 | $-0.74 | $-0.88 | -19.73% |
| Nov 6, 2019 | Sep 2019 | $-0.80 | $-0.38 | 52.74% |
| Aug 6, 2019 | Jun 2019 | $-0.60 | $-0.79 | -31.67% |
| May 7, 2019 | Mar 2019 | $-0.66 | $-0.36 | 45.45% |
| Mar 11, 2019 | Dec 2018 | $-0.72 | $-0.53 | 26.53% |
| Nov 13, 2018 | Sep 2018 | $-0.59 | $-0.54 | 8.47% |
| Aug 1, 2018 | Jun 2018 | $-0.58 | $-0.17 | 70.76% |
| May 7, 2018 | Mar 2018 | $-0.62 | $-0.71 | -13.91% |
| Mar 12, 2018 | Dec 2017 | $-0.68 | $-0.76 | -11.63% |
| Nov 13, 2017 | Sep 2017 | $-0.58 | $-0.73 | -26.96% |
| Aug 2, 2017 | Jun 2017 | $-0.59 | $-0.81 | -37.70% |
| May 9, 2017 | Mar 2017 | $-0.61 | $-0.58 | 6.12% |
| Mar 6, 2017 | Dec 2016 | $-0.34 | $-0.37 | -9.62% |
| Nov 22, 2016 | Sep 2016 | $-0.63 | $-0.38 | 39.65% |
| Sep 8, 2016 | Jun 2016 | $-0.42 | $-0.20 | 51.23% |
| May 11, 2016 | Mar 2016 | $-0.51 | $-0.96 | -90.00% |
| Mar 14, 2016 | Dec 2015 | $0.24 | $0.26 | 4.71% |
| Nov 19, 2015 | Sep 2015 | $-0.30 | $-0.40 | -33.33% |
| Sep 9, 2015 | Jun 2015 | $-0.36 | $-0.63 | -75.00% |
| Jun 9, 2015 | Mar 2015 | $-0.04 | $0.26 | 750.00% |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Mar 4, 2021 | Dec 2020 | $-1.80 | $-1.95 | - |
| Mar 4, 2020 | Dec 2019 | $-2.25 | $-2.41 | - |
| Mar 11, 2019 | Dec 2018 | $-1.97 | $-1.95 | - |
| Mar 12, 2018 | Dec 2017 | $-2.99 | $-2.87 | - |
| Mar 6, 2017 | Dec 2016 | - | $-1.92 | - |
| Mar 14, 2016 | Dec 2015 | - | $-0.51 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Aug 5, 2021 | Jun 2021 | $14.62M | $11.18M | 0.76% |
| May 6, 2021 | Mar 2021 | $7.80M | $25.60M | 3.28% |
| Mar 4, 2021 | Dec 2020 | $7.64M | $13.91M | 1.82% |
| Nov 5, 2020 | Sep 2020 | $10.79M | $9.24M | 0.86% |
| Aug 5, 2020 | Jun 2020 | $4.35M | $4.62M | 1.06% |
| May 6, 2020 | Mar 2020 | $16.23M | $4.62M | 0.28% |
| Mar 4, 2020 | Dec 2019 | $4.95M | $4.43M | 0.90% |
| Nov 6, 2019 | Sep 2019 | $3.28M | $8.49M | 2.59% |
| Aug 6, 2019 | Jun 2019 | $3.85M | $1.15M | 0.30% |
| May 7, 2019 | Mar 2019 | $4.45M | $3.43M | 0.77% |
| Mar 11, 2019 | Dec 2018 | $0.00 | $869.00K | - |
| Nov 13, 2018 | Sep 2018 | $8.66M | $905.00K | 0.10% |
| Aug 1, 2018 | Jun 2018 | $9.37M | $5.05M | 0.54% |
| May 7, 2018 | Mar 2018 | $8.93M | $8.06M | 0.90% |
| Mar 12, 2018 | Dec 2017 | $10.31M | $5.77M | 0.56% |
| Nov 13, 2017 | Sep 2017 | - | $6.12M | - |
| Aug 2, 2017 | Jun 2017 | - | $6.75M | - |
| May 9, 2017 | Mar 2017 | - | $6.77M | - |
| Mar 6, 2017 | Dec 2016 | - | $5.68M | - |
| Nov 22, 2016 | Sep 2016 | - | $11.32M | - |
| Sep 8, 2016 | Jun 2016 | - | $17.60M | - |
| May 11, 2016 | Mar 2016 | - | $7.95M | - |
| Mar 14, 2016 | Dec 2015 | - | $28.76M | - |
| Nov 19, 2015 | Sep 2015 | - | $8.55M | - |
| Sep 9, 2015 | Jun 2015 | - | $8.22M | - |
| Jun 9, 2015 | Mar 2015 | - | $9.05M | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Mar 4, 2021 | Dec 2020 | $73.43M | $73.95M | 0.71% |
| Mar 4, 2020 | Dec 2019 | $21.62M | $22.99M | 6.34% |
| Mar 11, 2019 | Dec 2018 | $21.43M | $21.43M | 0.00% |
| Mar 12, 2018 | Dec 2017 | $39.33M | $33.72M | -14.28% |
| Mar 6, 2017 | Dec 2016 | - | $53.77M | - |
| Mar 14, 2016 | Dec 2015 | - | $55.04M | - |
CLLS's next estimated earnings date (based on same quarter last year's report date) is Nov 5, 2021 for the fiscal quarter ending Sep 30, 2021.
Cellectis's previous earnings date was Aug 5, 2021 for its fiscal quarter ended Jun 30, 2021.
CLLS's earnings per share (EPS) was $-0.88, missing the consensus analysts forecast of $-0.73 by -21.38%.
The EPS was lower than the previous fiscal quarter (Mar 2021) by 214.29%, and lower than the same period a year before (Jun 2020) by 15.79%.
Revenues were $11.18M, worse than the forecast of $14.62M by -23.53%, down by -56.35% from the previous quarter , and up by 142.11% from the same period last year.
The company reported a net income of $-39.92M.Free cash flow for the quarter was $-17.58M , compared to $-49.14M last quarter and $-36.20M a year before.
CLLS ended the quarter with $105.59M in total debt.
Cellectis's previous annual earnings date was Mar 4, 2021 for its fiscal year ended Dec 31, 2020.
CLLS's earnings per share (EPS) was $-1.95, missing the consensus analysts forecast of $-1.80 by 8.33% , and higher than the previous year's EPS (Dec 2019) by -19.09%.
Revenues were $73.95M, better than the forecast of $73.43M by 0.71%, and up by 221.66% from previous year's revenue.
The company reported a net income of $-81.07M.
Cellectis reported a free cash flow of $-126.52M for its fiscal year, compared to $-82.10M a year ago.
The company ended the fiscal year with $35.53M in total debt, a decrease of -25.36% compared to the previous year.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.
